Allowable Excess Volume and Labeled Vial Fill Size in Injectable Drug and Biological Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 25, 2015
May 6, 2020
23e78a60-a44a-4fe0-840f-72c23de18934
Related Documents
Analytical Procedures and Methods Validation for Drugs and Biologics
Guidance DocumentJuly 27, 2015Center for Drug Evaluation and Research
General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry
Guidance DocumentJuly 27, 2022Center for Drug Evaluation and Research
Patient Counseling Information Section of Labeling for Human Prescription Drug and Biological Products — Content and Format
Guidance DocumentDecember 10, 2014Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox